Security Snapshot

EVOLENT HEALTH INC - NOTE 3.500%12/0 Institutional Ownership

CUSIP: 30050BAH4

13F Institutional Holders and Ownership History from Q4 2024 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

10

Principal

$135.42MFull value: $135,415,000 · USD principal · 30 Sep 2026

Price (% of par)

72.37%

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 3 signals
Principal change
-$3,468,000
Market value change
-$2,454,898
Number of holders
10
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported market price (% of par)
72.37%
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • 30050BAH4 - EVOLENT HEALTH INC - NOTE 3.500%12/0 is tracked under CUSIP 30050BAH4.
  • 10 institutions reported positions in Q3 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 20 to 10 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $285.25MFull value: $285,251,402 · USD · 30 Jun 2026
    to
    $98.22MFull value: $98,215,564 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 10 institutions filings for Q3 2026.

Open SEC evidence

Security key

30050BAH4

13F reference period

Q3 2026

13F holders

10

13D/G owners

0

CIK / CUSIP context first

As of 30 Sep 2026, 10 institutional investors reported holding
$135.42MFull value: $135,415,000 · USD · 30 Sep 2026 · Principal (par value)
in principal (par value) of EVOLENT HEALTH INC - NOTE 3.500%12/0.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
8
Headline period
Q3 2026
Rows shown
1-8 of 8
Period Principal Value Change Price (% of par) (Median) Investors
2026 Q3 $135,415,000 $98,215,564 -$2,454,898 72.37% 10
2026 Q2 $381,219,450 $285,251,402 +$26,819,671 74.39% 20
2026 Q1 $346,300,450 $187,857,115 -$15,642,050 53.47% 22
2025 Q4 $368,939,000 $249,842,369 +$38,603,365 67.16% 29
2025 Q3 $306,999,214 $248,750,623 -$14,271,109 80.55% 32
2025 Q2 $329,020,914 $326,611,769 +$2,774,073 85.0% 29
2025 Q1 $340,809,567 $278,584,497 -$44,438,128 81.36% 36
2024 Q4 $380,033,102 $325,228,058 +$323,325,458 85.06% 30
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .